Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3597 | 1947 | 32.7 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
98 | 3 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//SURGERY | 75394 |
93 | 2 | TRANSPLANTATION//TRANSPLANTATION PROCEEDINGS//KIDNEY TRANSPLANTATION | 26351 |
3597 | 1 | SIROLIMUS//EVEROLIMUS//BELATACEPT | 1947 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SIROLIMUS | authKW | 2348315 | 24% | 32% | 471 |
2 | EVEROLIMUS | authKW | 766771 | 13% | 20% | 246 |
3 | BELATACEPT | authKW | 325744 | 2% | 48% | 43 |
4 | PROLIFERATION SIGNAL INHIBITORS | authKW | 237681 | 1% | 63% | 24 |
5 | IMMUNOL ORGAN TRANSPLANTAT | address | 215850 | 3% | 26% | 53 |
6 | SDZ RAD | authKW | 176675 | 1% | 87% | 13 |
7 | CALCINEURIN INHIBITOR | authKW | 167504 | 3% | 19% | 57 |
8 | CALCINEURIN INHIBITORS | authKW | 131316 | 3% | 14% | 61 |
9 | RAPAMYCIN | authKW | 130583 | 7% | 6% | 144 |
10 | TRANSPLANTATION | WoSSC | 128084 | 53% | 1% | 1034 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Transplantation | 128084 | 53% | 1% | 1034 |
2 | Surgery | 15468 | 48% | 0% | 928 |
3 | Immunology | 10885 | 36% | 0% | 707 |
4 | Medical Laboratory Technology | 3453 | 7% | 0% | 140 |
5 | Urology & Nephrology | 3420 | 13% | 0% | 249 |
6 | Pharmacology & Pharmacy | 1134 | 16% | 0% | 316 |
7 | Toxicology | 333 | 5% | 0% | 91 |
8 | Biochemical Research Methods | 55 | 3% | 0% | 54 |
9 | Respiratory System | 46 | 2% | 0% | 37 |
10 | Pediatrics | 29 | 2% | 0% | 47 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNOL ORGAN TRANSPLANTAT | 215850 | 3% | 26% | 53 |
2 | KIDNEY TRANSPLANT SERV | 66884 | 1% | 27% | 16 |
3 | NEPHROL DIALYSIS ORGAN TRANSPLANTAT | 63805 | 1% | 24% | 17 |
4 | PUBL MED SOCIAL HLTH | 50179 | 0% | 80% | 4 |
5 | NEPHROL | 35530 | 20% | 1% | 380 |
6 | ALLGEMEINE PHARMAKOL | 34917 | 0% | 32% | 7 |
7 | UNIDAD TRANSPLANTE RENAL | 33200 | 0% | 35% | 6 |
8 | AUSTRALIAN BIOANALYT SERV PTY LTD | 32664 | 0% | 42% | 5 |
9 | BUSINESS UNIT TRANSPLANTAT | 31363 | 0% | 100% | 2 |
10 | CENT PA TRANSPLANT ASSOCIATES | 31363 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TRANSPLANTATION PROCEEDINGS | 60322 | 20% | 1% | 392 |
2 | TRANSPLANTATION | 47055 | 12% | 1% | 235 |
3 | AMERICAN JOURNAL OF TRANSPLANTATION | 31635 | 5% | 2% | 98 |
4 | TRANSPLANT INTERNATIONAL | 24232 | 4% | 2% | 69 |
5 | THERAPEUTIC DRUG MONITORING | 22291 | 4% | 2% | 73 |
6 | CLINICAL TRANSPLANTATION | 15132 | 3% | 2% | 60 |
7 | PEDIATRIC TRANSPLANTATION | 7402 | 2% | 1% | 33 |
8 | EXPERIMENTAL AND CLINICAL TRANSPLANTATION | 4692 | 1% | 2% | 17 |
9 | TRANSPLANTATION REVIEWS | 4232 | 0% | 4% | 7 |
10 | CURRENT OPINION IN ORGAN TRANSPLANTATION | 2431 | 1% | 1% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SIROLIMUS | 2348315 | 24% | 32% | 471 | Search SIROLIMUS | Search SIROLIMUS |
2 | EVEROLIMUS | 766771 | 13% | 20% | 246 | Search EVEROLIMUS | Search EVEROLIMUS |
3 | BELATACEPT | 325744 | 2% | 48% | 43 | Search BELATACEPT | Search BELATACEPT |
4 | PROLIFERATION SIGNAL INHIBITORS | 237681 | 1% | 63% | 24 | Search PROLIFERATION+SIGNAL+INHIBITORS | Search PROLIFERATION+SIGNAL+INHIBITORS |
5 | SDZ RAD | 176675 | 1% | 87% | 13 | Search SDZ+RAD | Search SDZ+RAD |
6 | CALCINEURIN INHIBITOR | 167504 | 3% | 19% | 57 | Search CALCINEURIN+INHIBITOR | Search CALCINEURIN+INHIBITOR |
7 | CALCINEURIN INHIBITORS | 131316 | 3% | 14% | 61 | Search CALCINEURIN+INHIBITORS | Search CALCINEURIN+INHIBITORS |
8 | RAPAMYCIN | 130583 | 7% | 6% | 144 | Search RAPAMYCIN | Search RAPAMYCIN |
9 | MTOR INHIBITOR | 124254 | 3% | 12% | 67 | Search MTOR+INHIBITOR | Search MTOR+INHIBITOR |
10 | CERTICAN | 112005 | 1% | 71% | 10 | Search CERTICAN | Search CERTICAN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHIPKOVA, M , HESSELINK, DA , HOLT, DW , BILLAUD, EM , VAN GELDER, T , KUNICKI, PK , BRUNET, M , BUDDE, K , BARTEN, MJ , DE SIMONE, P , ET AL (2016) THERAPEUTIC DRUG MONITORING OF EVEROLIMUS: A CONSENSUS REPORT.THERAPEUTIC DRUG MONITORING. VOL. 38. ISSUE 2. P. 143 -169 | 117 | 59% | 1 |
2 | ZHAO, DQ , LI, SW , SUN, QQ , (2016) SIROLIMUS-BASED IMMUNOSUPPRESSIVE REGIMENS IN RENAL TRANSPLANTATION: A SYSTEMIC REVIEW.TRANSPLANTATION PROCEEDINGS. VOL. 48. ISSUE 1. P. 3 -9 | 66 | 97% | 2 |
3 | SAWINSKI, D , TROFE-CLARK, J , LEAS, B , UHL, S , TUTEJA, S , KACZMAREK, JL , FRENCH, B , UMSCHEID, CA , (2016) CALCINEURIN INHIBITOR MINIMIZATION, CONVERSION, WITHDRAWAL, AND AVOIDANCE STRATEGIES IN RENAL TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS.AMERICAN JOURNAL OF TRANSPLANTATION. VOL. 16. ISSUE 7. P. 2117 -2138 | 72 | 78% | 3 |
4 | AUGUSTINE, JJ , BODZIAK, KA , HRICIK, DE , (2007) USE OF SIROLIMUS IN SOLID ORGAN TRANSPLANTATION.DRUGS. VOL. 67. ISSUE 3. P. 369-391 | 101 | 66% | 107 |
5 | PIERI, M , MIRAGLIA, N , POLICHETTI, G , TARANTINO, G , ACAMPORA, A , CAPONE, D , (2011) ANALYTICAL AND PHARMACOLOGICAL ASPECTS OF THERAPEUTIC DRUG MONITORING OF MTOR INHIBITORS.CURRENT DRUG METABOLISM. VOL. 12. ISSUE 3. P. 253 -267 | 86 | 72% | 16 |
6 | KUYPERS, DRJ , (2005) BENEFIT-RISK ASSESSMENT OF SIROLIMUS IN RENAL TRANSPLANTATION.DRUG SAFETY. VOL. 28. ISSUE 2. P. 153-181 | 118 | 58% | 76 |
7 | HALLECK, F , DUERR, M , WAISER, J , HUBER, L , MATZ, M , BRAKEMEIER, S , LIEFELDT, L , NEUMAYER, HH , BUDDE, K , (2012) AN EVALUATION OF SIROLIMUS IN RENAL TRANSPLANTATION.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 8. ISSUE 10. P. 1337 -1356 | 104 | 57% | 8 |
8 | SANCHEZ-FRUCTUOSO, AI , (2008) EVEROLIMUS: AN UPDATE ON THE MECHANISM OF ACTION, PHARMACOKINETICS AND RECENT CLINICAL TRIALS.EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. VOL. 4. ISSUE 6. P. 807-819 | 83 | 68% | 25 |
9 | SHIHAB, F , CHRISTIANS, U , SMITH, L , WELLEN, JR , KAPLAN, B , (2014) FOCUS ON MTOR INHIBITORS AND TACROLIMUS IN RENAL TRANSPLANTATION: PHARMACOKINETICS, EXPOSURE-RESPONSE RELATIONSHIPS, AND CLINICAL OUTCOMES.TRANSPLANT IMMUNOLOGY. VOL. 31. ISSUE 1. P. 22 -32 | 47 | 89% | 16 |
10 | MOES, DJAR , GUCHELAAR, HJ , DE FIJTER, JW , (2015) SIROLIMUS AND EVEROLIMUS IN KIDNEY TRANSPLANTATION.DRUG DISCOVERY TODAY. VOL. 20. ISSUE 10. P. 1243 -1249 | 53 | 72% | 13 |
Classes with closest relation at Level 1 |